Chemistry:Sutezolid
From HandWiki
Sutezolid is an investigational new drug that is being evaluated for the treatment of extensively drug-resistant tuberculosis.[1] It differs from linezolid by replacement of the morpholine oxygen with a sulfur atom. Like linezolid, sutezolid is a bacterial protein synthesis inhibitor. In preclinical studies, sutezolid demonstrated superior antituberculosis activity compared to linezolid.[2]
References
- ↑ "Sutezolid - Global Alliance for TB Drug Development/Sequella". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800006585.
- ↑ "New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?". Pharmaceutics 16 (6): 818. June 2024. doi:10.3390/pharmaceutics16060818. PMID 38931939.
 |  |
